InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TGZ | Ann: ASX Delisting Letter | 14/09/17 | 0 | 719 | |||
|
|||||||
TGZ | Ann: Press Release - Golden Hill Results | 14/09/17 | 0 | 334 | |||
|
|||||||
TGZ | Ann: Removal from Official List | 13/09/17 | 0 | 291 | |||
|
|||||||
TGZ | Ann: Press Release - Hedging | 12/09/17 | 0 | 215 | |||
|
|||||||
TGZ | Ann: Suspension - Close of Trading 8 September 2017 | 08/09/17 | 0 | 330 | |||
|
|||||||
TGZ | Ann: ASX Suspension Letter | 08/09/17 | 0 | 273 | |||
|
|||||||
TGZ | Ann: Press Release - Banfora Development | 08/09/17 | 0 | 195 | |||
|
|||||||
TGZ | Ann: Appendix 3B | 06/09/17 | 0 | 172 | |||
|
See All Discussions